What Clinical Evidence Shows About These Treatments
Mounjaro vs Wegovy: Understanding the Clinical Trial Evidence
When comparing Mounjaro vs Wegovy for weight loss results in the UK, it's essential to examine the robust clinical trial data that supports both treatments. Wegovy (semaglutide) demonstrated impressive outcomes in the landmark STEP clinical trials, with patients achieving an average of ~clinically studied weight loss at 68 weeks when combined with lifestyle interventions. The STEP 1 trial, published by Wilding et al. in the New England Journal of Medicine (2021), showed that patients taking Wegovy alongside diet and exercise lost significantly more weight compared to placebo groups. Mounjaro (tirzepatide) has shown its own compelling results through the SURMOUNT trial programme, though direct head-to-head comparisons aren't available due to different trial designs and patient populations.
Both prescription-only medicines work by targeting appetite regulation, but through different pathways that may influence individual responses. Wegovy activates GLP-1 receptors exclusively, while Mounjaro targets both GIP and GLP-1 receptors as a dual agonist. This mechanistic difference means that when considering Mounjaro vs Wegovy, patients may experience varying degrees of appetite suppression, satiety, and weight loss outcomes based on their individual physiology. Clinical assessment is crucial to determine which approach may be more suitable for your specific circumstances and medical history.
Pricing Comparison: Mounjaro vs Wegovy UK Costs
Understanding the cost structure when comparing Mounjaro vs Wegovy helps inform treatment decisions alongside clinical considerations. At EverydayMeds, Wegovy pricing starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose (£209.99). Our Getting Started bundles provide convenient dosing transitions, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, making the initial treatment phase more manageable. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 to access these competitive prices.
Both treatments require systematic dose escalation to minimise side effects and optimise tolerance, which means budgeting for several months of treatment. Our Step-Up bundles, including the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99, provide three months of progressive dosing in one convenient order. For patients reaching maintenance doses, the Ultimate Stability Trio offers three 2.4mg pens for £649.99, ensuring consistent supply. When evaluating Mounjaro vs Wegovy costs, remember that both are prescription-only medicines requiring ongoing clinical monitoring and should be viewed as long-term investments in your health alongside lifestyle modifications.
Wegovy Clinical Evidence: STEP Trial Results Breakdown
The STEP clinical trial programme provides the foundation for understanding Wegovy's weight loss potential when comparing Mounjaro vs Wegovy outcomes. In STEP 1, patients taking Wegovy alongside reduced-calorie diet and increased physical activity achieved an average weight reduction of approximately 15% at 68 weeks, compared to 2.4% with placebo. STEP 3 demonstrated even higher results of ~clinically studied weight loss when intensive behavioural therapy was included alongside Wegovy treatment.
Long-term sustainability data from STEP 5 showed that patients maintained approximately clinically studied weight loss at two years, highlighting Wegovy's potential for sustained results. The recent SELECT cardiovascular outcomes trial revealed that Wegovy reduced major adverse cardiovascular events by 20% in adults with established cardiovascular disease, adding an important safety and efficacy dimension to the Mounjaro vs Wegovy comparison. These results represent outcomes in clinical trial settings and individual results may vary based on adherence, lifestyle factors, and medical history.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding the mechanism of action helps clarify the differences when comparing Mounjaro vs Wegovy for weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone produced in your intestines after eating. This hormone signals to your brain's appetite centres, promoting feelings of fullness and reducing food cravings throughout the day. By slowing gastric emptying, Wegovy helps you feel satisfied with smaller portion sizes, supporting the calorie deficit necessary for weight loss. The once-weekly injection provides consistent hormone levels, maintaining these appetite-regulating effects between doses. This targeted approach to appetite control works synergistically with reduced-calorie diet and increased physical activity to support meaningful weight management outcomes.
EverydayMeds Ordering Process for Weight Loss Treatments
Accessing either treatment in our Mounjaro vs Wegovy comparison begins with our streamlined three-minute online clinical assessment, designed to gather essential medical history and current health information. Our UK-registered prescribers (GPhC #9012878) review every application thoroughly, typically within three working days, though express 24-hour reviews are available when needed. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our pharmacy team coordinates timing to ensure you're ready to begin treatment with proper injection technique guidance and ongoing support. The entire process, from assessment to delivery, is designed to provide convenient access while maintaining the highest clinical and pharmaceutical standards for these important weight management medications.
Storage and Practical Considerations: Wegovy vs Mounjaro
Practical differences between treatments can influence your choice when weighing Mounjaro vs Wegovy options for daily life integration. Wegovy offers a storage advantage with its ability to remain at room temperature (below 30°C) for up to six weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications use pre-filled injection pens, though Wegovy's FlexTouch pen system provides dose escalation through separate pen strengths rather than dial adjustments. The weekly injection schedule for both treatments offers convenience compared to daily medications, fitting easily into most lifestyle routines. Proper refrigerated storage at 2-8°C before first use is essential for both medications, and our delivery service includes insulated packaging to maintain cold-chain integrity. Understanding these practical aspects helps ensure treatment success regardless of which option you and your prescriber select.
UK Weight Management: Real-World Mounjaro vs Wegovy Considerations
When evaluating Mounjaro vs Wegovy in the UK healthcare context, both treatments align with NICE guidance for specialist weight management support alongside pharmacological intervention. Wegovy received NICE recommendation TA875, recognising its role in comprehensive weight management programmes that include dietary counselling and physical activity support. The treatments complement existing NHS weight management services, though private prescription access through registered pharmacies like EverydayMeds provides more flexible timing and convenience.
Both medications require ongoing medical supervision, making the prescriber relationship crucial regardless of your choice in the Mounjaro vs Wegovy decision. UK patients benefit from MHRA oversight ensuring medication safety and efficacy standards, with both treatments subject to additional monitoring as newer therapeutic options. Success with either treatment depends significantly on commitment to lifestyle modifications, making professional support and patient education essential components of effective weight management strategies.
Making Your Treatment Decision: Expert Guidance Available
The choice between treatments in any Mounjaro vs Wegovy comparison ultimately depends on individual medical factors, lifestyle considerations, and personal response patterns that only qualified prescribers can properly evaluate. At EverydayMeds, our clinical team provides personalised guidance based on your health history, current medications, previous weight management attempts, and treatment goals. Both medications are available through our service, ensuring you can access whichever option best suits your circumstances without being limited by formulary restrictions. Starting your clinical assessment today with discount codes FIRST40 for new customers or DOSE25 for returning patients puts you one step closer to evidence-based weight management support. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine, properly stored medications with comprehensive support throughout your treatment journey, whether you choose Wegovy, Mounjaro, or transition between options under medical supervision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
